Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection

[Image: see text] The urgency to find complementary therapies to current SARS-CoV-2 vaccines, whose effectiveness is preserved over time and not compromised by the emergence of new and emerging variants, has become a critical health challenge. We investigate the possibility of jamming the opening of...

Descripción completa

Detalles Bibliográficos
Autores principales: Stagnoli, Soledad, Macari, Gabriele, Corsi, Pietro, Capone, Barbara, Vidaurrazaga, Ander, Ereño-Orbea, June, Ardá, Ana, Polticelli, Fabio, Jiménez-Barbero, Jesús, Abrescia, Nicola GA, Coluzza, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666140/
https://www.ncbi.nlm.nih.gov/pubmed/38027314
http://dx.doi.org/10.1021/acsomega.3c02921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666140/
https://www.ncbi.nlm.nih.gov/pubmed/38027314
http://dx.doi.org/10.1021/acsomega.3c02921

Ejemplares similares